Evaluating the Role of Genetic Markers in Prostate Cancer Progression: A Multiethnic Cohort Experience

Abstract

Most prostate cancer (PCa) research has focused on risk, little is known about predictors of progression and even less about how these factors differ by ethnicity/race. Strong racial disparities in mortality have shown that African- Americans are twice as likely to die from PCa compared to Caucasians; very little data are available in Hispanics. Our overall goal is to identify markers related to PCa progression in a multiethnic cohort of 773 Caucasians, 361 African-Americans, and 246 Mexican-Americans, for whom we have already collected information. We have abstracted medical records for 1200 patients and are requesting copies of outside medical records for those who received care outside our institution, as well as continuing to abstract medical records. Additionally, we are matching our database with the National Death Index to update vital status. We are multi-plexing the genotyping assays to optimize the utilization of our archived specimens, and all DNA extractions have been completed. Our research may help explain ethnic/racial disparities in PCa progression and provide direction towards eliminating these disparities and may guide future studies to develop ethnic/racial specific interventions to improve outcome in the most common cancer in American men.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Oct 01, 2009
Accession Number
ADA520021

Entities

People

  • Sara S. Strom

Organizations

  • The University of Texas MD Anderson Cancer Center

Tags

DTIC Thesaurus Topics

  • Abstracts
  • African Americans
  • Cardiovascular Physiological Phenomena
  • Caucasians
  • Databases
  • Disparities
  • Ethnic Groups
  • Health
  • Health Care
  • Health Services
  • Hypertension
  • Medical Personnel
  • Myocardial Ischemia
  • Neoplasms
  • Prostate Cancer

Readers

  • Gender and Food Studies
  • Gulf War Illness and Chronic Multisymptom Illness in Veterans.
  • Oncology (Cancer Research).

Technology Areas

  • Biotechnology